secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2021-10-25T23:59:59+00:00
Accession:  0000950170-21-002274
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medpace Q3 revenue $295.6M (+28.3%), EPS $1.29; net new awards $408M
--------------------------------------------------------------------

- Revenue $295.6M, up 28.3% YoY; net income $48.6M ($1.29 diluted EPS) vs $41.5M ($1.09) prior year.
- Net new business awards $408M, up 29.4%, book-to-bill 1.38x; backlog $1.8B (+29%).
- EBITDA $60.1M (20.3% margin) vs $51.9M (22.5%) prior year; net income margin 16.4% vs 18%.
- Constant currency organic revenue growth 28.1%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000095017021002274/0000950170-21-002274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000095017021002274/medp-20211025.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-002274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer